Showing results (11-20 of 237) with videos related to
Sort By:
Pageof 24
International Journal of Hematology|January 31, 2007
Clinical features of hypereosinophilic syndrome: FIP1L1-PDGFRA fusion gene-positive disease is a distinct clinical entity with myeloproliferative features and a poor response to corticosteroidKeisuke Miyazawa, Naoki Kakazu, Kazuma OhyashikiAnnals of Hematology|February 16, 2005
Increased intracellular activity of matrix metalloproteinases in neutrophils may be associated with delayed healing of infection without neutropenia in myelodysplastic syndromesNoritaka Yamaguchi, Yoshikazu Ito, Kazuma OhyashikiExperimental Hematology|May 18, 2010
Establishment of a new Philadelphia chromosome-positive acute lymphoblastic leukemia cell line (SK-9) with T315I mutationSeiichi Okabe, Tetsuzo Tauchi, Kazuma OhyashikiAnnals of Hematology|June 22, 2010
Efficacy of MK-0457 and in combination with vorinostat against Philadelphia chromosome positive acute lymphoblastic leukemia cellsSeiichi Okabe, Tetsuzo Tauchi, Kazuma OhyashikiCurrent Opinion in Hematology|February 12, 2016
Exosomes promote bone marrow angiogenesis in hematologic neoplasia: the role of hypoxiaJunko H Ohyashiki, Tomohiro Umezu, Kazuma OhyashikiLeukemia Research|May 3, 2005
Methylation of p15(INK4b) and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemiaTakashi Shimamoto, Junko H Ohyashiki, Kazuma OhyashikiMethods in Molecular Biology (Clifton, N.J.)|March 25, 2011
Cytogenetics in myelodysplastic syndromesKazuma Ohyashiki, Atsushi Kodama, Junko H OhyashikiCancer Genetics and Cytogenetics|September 13, 2008
Recurrent der(9;18) in essential thrombocythemia with JAK2 V617F is highly linked to myelofibrosis developmentKazuma Ohyashiki, Atsushi Kodama, Junko H OhyashikiPhilosophical Transactions of the Royal Society of London. Series B, Biological Sciences|November 22, 2017
Extracellular vesicle-mediated cell-cell communication in haematological neoplasmsJunko H Ohyashiki, Tomohiro Umezu, Kazuma OhyashikiMethods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Telomerase inhibition combined with other chemotherapeutic reagents to enhance anti-cancer effectTetsuzo Tauchi, Junko H Ohyashiki, Kazuma OhyashikiPageof 24